Ads
related to: treating severe asthma- What Is E-Asthma?
Visit The Official Patient Site To
Learn About Your Asthma Condition.
- Sign Up For Email Updates
Receive Personalized Resources For
Your Asthma Journey, Sign Up.
- Patient Support Tools
Access Different Asthma Resources
That Are Available To You.
- Find An Asthma Specialist
Take Control Of Your Asthma
Condition & Find A Doctor Near You.
- Pay As Little As $0
Get Information About A Savings
Program & Learn If You Are Eligible
- Access The FAQ Page
Get Your Asthma & Treatment
Questions Answered At The Site.
- What Is E-Asthma?
Search results
GERD and LPR: Similar, But Different Reflux Conditions
Verywell Health via Yahoo News· 2 days agoAcid in the throat and inflammation could cause other problems in the long term. LPR may be associated with other conditions, such as: Asthma Chronic cough Chronic ear infections ...
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks· 5 days agoBayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.
Docs reveal how to avoid dreaded ‘festival flu’
NY Post via Yahoo News· 5 days agoSoaking feet in vinegar is one way to prevent and treat the dreaded playa foot. Hygiene is key when coming into contact with so many people. TNS Practice...
Disposing End-Of-Life Electronics To Improve The Lives Of People: RAKI's Futuristic Mission Vision
International Business Times· 5 days agoA mountain of electronic waste created by the global culture of 'use and throw-away' is hiding...
7 Best Cough Medicines for Kids, Ranked by Pharmacists 2024
US News Health· 3 days agoOver-the-counter cough medications help reduce the urge to cough, loosen mucus that may cause a cough, relieve a stuffy nose and decrease inflammation caused by infection. OTC cough medications ...
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at...
Benzinga· 2 days agoDupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS...
Benzinga· 2 days agoNOTUS results confirm landmark data from the Phase 3 BOREAS trial and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive
Health officials say politicians, utilities ignore health impacts of Colstrip pollution
Billings Gazette· 7 days agoColstrip Power Plant owners and politicians are ignoring the public health impacts of air toxics...
Morning Brew: MicroStrategy Soars on MSCI Inclusion, Walmart Bea
Guru Focus· 6 days agoToday's stock market is showing positive signs with slight gains across major indices. Here's a...
Britain covered up tainted blood scandal that killed thousands, report finds
UPI· 2 days ago1 of 3 | The British government “did not put patient safety first” while covering up a multi-decade...
Ads
related to: treating severe asthma
